Lorenil 2%

Antifungal Cream

Composition :

100 g of cream contain: active ingredient fenticonazole nitrate 2 g. Excipients: hydrogenated lanolin; cetyl alcohol For the full list of excipients see section 6.1.

Excipients

Propylene glycol; hydrogenated lanolin; sweet almond oil; polyglycol ester of fatty acids; cetyl alcohol; glyceryl monostearate; sodium edetate; purified water.

Therapeutic indications

- Dermatomycosis caused by dermatophytes (Trichophyton, Microsporum, Epidermiphyton) with different localization: tinea capitis, tinea corporis, tinea cruris, tinea pedis (athlete's foot), tinea manuum, tinea faciei, tinea barbae, tinea unguium. - Skin candidiasis (intertrigo, perleche, facial candidiasis, 'diaper', perineal and scrotal candidiasis); balanitis, balanoposthitis, onychia and paronychia. - Pityriasis versicolor (from Pityrosporum orbiculare and P. ovale) - Otomycosis (from Candida or molds); only if no eardrum lesions are present. - Erythrasma. - Mycosis with bacterial superinfections (from Gram positive bacteria).

Contraindications

Hypersensitivity to the active substance or to any of the excipients.

Dosage

Lorenil should be applied 1-2 times a day, according to the doctor's opinion, after washing and drying the injured part, using the formulation suitable for the location of the lesion. The cream is indicated for the treatment of hairless skin, skin folds and mucous membranes; it is applied by rubbing lightly. Lorenil cream is used preferentially for dry mycoses: Pityriasis versicolor, erythrasma, onychomycosis (in onychomycosis the cream should be applied with an occlusive bandage); the cream is suitable for use in male genital mycosis. Lorenil treatments should be performed regularly until the lesions have completely disappeared. Lorenil is not greasy, does not stain and can be easily removed with water.

Warnings and Precautions

The use, especially if prolonged, of products for topical use, can give rise to sensitization phenomena. At the time of application on the lesion, a modest burning sensation may be found which disappears quickly.

Interactions

Not known.

Side effects

Lorenil is generally well tolerated, both on the skin and on the mucous membranes; only exceptionally mild and transient erythematous reactions have been reported. In the event of hypersensitivity reactions or the development of resistant microorganisms, treatment must be discontinued. Lorenil in the recommended conditions of use is only poorly absorbed, therefore systemic repercussions can be excluded.

Pregnancy and breastfeeding

Although the absorption of the drug is poor, the use of Lorenil during pregnancy and lactation is not recommended except in special cases and after a careful evaluation of the benefit / risk ratio by the doctor.